<DOC>
	<DOCNO>NCT01161199</DOCNO>
	<brief_summary>Despite dramatic improvement result combination antiretroviral treatment , long-term efficacy , toxicity , cost , requirement life-long adherence remain formidable challenge . Also , emerge consensus persistent HIV-associated disease occur long-term highly active antiretroviral therapy ( HAART ) . This disease may due either direct drug-toxicity and/or persistent viral replication/production and/or persistent HIV-associated inflammation . Hence , strategy aim achieve complete viral eradication may need order fully restore health among HIV infect individual . Even complete eradication prove impossible—as believe case—a less rigorous still desirable outcome might achieve durable control virus absence therapy . That `` functional '' cure possible well illustrate rare individual able durably control replication competent virus absence therapy ( `` elite '' controller ) . A complete understanding relationship inflammation viral persistence necessary rationale study HIV eradication design . Also , well validated high through-put virologic assay need developed estimate size latent reservoir . Since level replication competent virus long-term treated patient ( elite controller ) small ( &lt; 1 % CD4 cell harbor HIV ) , large number CD4+ T cell obtain study participant order routinely isolate quantify virus persistence .</brief_summary>
	<brief_title>The Use Leukapheresis Support HIV Pathogenesis Studies</brief_title>
	<detailed_description />
	<criteria>HIV seropositive Able give informed consent Willing undergo blood sample and/or leukapheresis Meeting one follow criterion : ( 1 ) stable highly active antiretroviral therapy ( HAART ) recent undetectable viral load ( &lt; 50 copies/mL ) ( `` HAART suppress '' ) , ( 2 ) antiretroviral untreated undetectable viral load ( &lt; 50 copies/mL ) ( `` elite '' controller ) ( 3 ) antiretroviral untreated detectable viral load ( &gt; 1000 copies/mL ) ( `` noncontrollers '' ) Known anemia ( HIV+ males Hct &lt; 34 ; female Hct &lt; 32 ) contraindication donate blood Blood coagulation disorder ( include bleed tendency problem past blood clot ) Platelets &lt; 50,000/mm3 PTT &gt; 2x ULN INR &gt; 1.5 Albumin &lt; 2.0 g/dL ALT &gt; 5x ULN AST &gt; 5x ULN Biopsyproven clinical diagnosis cirrhosis Weight &lt; 120 lb High blood pressure &gt; 160/100 Low blood pressure &lt; 100/70 Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>HIV</keyword>
	<keyword>latent reservoir</keyword>
	<keyword>functional cure</keyword>
	<keyword>leukapheresis</keyword>
</DOC>